495 related articles for article (PubMed ID: 25439569)
1. Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wuyts WA; Antoniou KM; Borensztajn K; Costabel U; Cottin V; Crestani B; Grutters JC; Maher TM; Poletti V; Richeldi L; Vancheri C; Wells AU
Lancet Respir Med; 2014 Nov; 2(11):933-942. PubMed ID: 25439569
[TBL] [Abstract][Full Text] [Related]
2. Nintedanib in the treatment of idiopathic pulmonary fibrosis.
Mazzei ME; Richeldi L; Collard HR
Ther Adv Respir Dis; 2015 Jun; 9(3):121-9. PubMed ID: 25862013
[TBL] [Abstract][Full Text] [Related]
3. [Nintedanib in the treatment of fibrosing interstital lung diseases].
Lewandowska K
Pol Merkur Lekarski; 2018 Mar; 44(261):139-141. PubMed ID: 29601564
[TBL] [Abstract][Full Text] [Related]
4. Management of patients with fibrosing interstitial lung diseases.
Morrow LE; Hilleman D; Malesker MA
Am J Health Syst Pharm; 2022 Jan; 79(3):129-139. PubMed ID: 34608488
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the medical treatment of idiopathic pulmonary fibrosis.
Xaubet A; Molina-Molina M; Acosta O; Bollo E; Castillo D; Fernández-Fabrellas E; Rodríguez-Portal JA; Valenzuela C; Ancochea J
Arch Bronconeumol; 2017 May; 53(5):263-269. PubMed ID: 28292522
[TBL] [Abstract][Full Text] [Related]
7. Precision medicine advances in idiopathic pulmonary fibrosis.
Karampitsakos T; Juan-Guardela BM; Tzouvelekis A; Herazo-Maya JD
EBioMedicine; 2023 Sep; 95():104766. PubMed ID: 37625268
[TBL] [Abstract][Full Text] [Related]
8. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program.
Richeldi L; du Bois RM
Expert Rev Respir Med; 2011 Aug; 5(4):473-81. PubMed ID: 21859266
[TBL] [Abstract][Full Text] [Related]
10. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report.
Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T
BMC Pulm Med; 2016 Mar; 16():38. PubMed ID: 26940352
[TBL] [Abstract][Full Text] [Related]
11. [Update in interstitial lung disease 2021].
Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jan; 45(1):95-99. PubMed ID: 35000313
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy.
Spagnolo P; Maher TM; Richeldi L
Pharmacol Ther; 2015 Aug; 152():18-27. PubMed ID: 25946646
[TBL] [Abstract][Full Text] [Related]
13. Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?
Joos GF; Gabazza EC
Respirology; 2015 Jan; 20(1):15-23. PubMed ID: 25410652
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.
Okuda R; Hagiwara E; Baba T; Kitamura H; Kato T; Ogura T
Respir Med; 2013 Sep; 107(9):1431-7. PubMed ID: 23849626
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
Nathan SD; Martinez FJ
Curr Opin Pulm Med; 2017 Sep; 23(5):426-431. PubMed ID: 28771451
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
18. Autophagy in lung disease pathogenesis and therapeutics.
Ryter SW; Choi AM
Redox Biol; 2015; 4():215-25. PubMed ID: 25617802
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis.
Xaubet A; Ancochea J; Molina-Molina M
Med Clin (Barc); 2017 Feb; 148(4):170-175. PubMed ID: 27998476
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
